WebGALAFOLD is an alpha-galactosidase A (alpha-Gal A) pharmacological chaperone indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data. WebFeb 1, 2024 · Galafold may cause serious side effects including: hives, difficulty breathing, swelling of your face, lips, tongue, or throat, and. pain or burning when you urinate. Get medical help right away, if you have any …
Amicus: More Upside For Galafold - SeekingAlpha
WebIMPORTANT SAFETY INFORMATION AND INDICATION Before taking Galafold (migalastat), tell your healthcare provider about all of your medical conditions, including if you: have kidney problems. are pregnant or plan to become pregnant. It is not known if Galafold will harm your unborn baby. WebAug 2, 2024 · “The approval of Galafold ® in Argentina marks a significant step for our oral precision medicine for Fabry disease in Latin America,” stated John F. Crowley, … hackear nintendo 2ds xl
Drug Trials Snapshots: GALAFOLD FDA
WebA total of 1 drugs are known to interact with Galafold: 1 moderate drug interactions (2 brand and generic names) A total of 4 drugs are known to interact with Fabrazyme: 3 major drug interactions (13 brand and generic names) 1 moderate drug interactions (2 brand and generic names) A total of 4 drugs are known to interact with agalsidase beta: WebDec 1, 2024 · Galafold is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene ( GLA) variant based on in vitro assay data [see Dosage and Administration ( 2.1) and Clinical Pharmacology ( 12.1 )]. WebGalafold ® (migalastat) is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene ( GLA) variant based on in vitro assay data. This indication is approved under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. hackearonline.com 2018